Literature DB >> 24515678

Differences in anxiety among patients with early- versus late-onset Alzheimer's disease.

Natalie C Kaiser, Li-Jung Liang, Rebecca J Melrose, Stacy S Wilkins, David L Sultzer, Mario F Mendez.   

Abstract

The authors sought to evaluate the incidence and correlates of anxiety in early-onset Alzheimer's disease (EOAD) versus the more typical late-onset AD (LOAD). A group of 23 EOAD and 22 LOAD patients were compared by the Neuropsychiatric Inventory Anxiety subscale. Demographic and disease-related relationships with anxiety were evaluated, as well as types of anxiety symptoms that were endorsed. EOAD patients had significantly more anxiety symptoms than LOAD patients. Among those with EOAD, anxiety was associated with male gender, higher Mini-Mental State Exam score, and separation from caregivers. Among LOAD patients, anxiety was associated with psychotic and activating psychiatric symptoms. These results have implications for the management and alleviation of anxiety in AD.

Entities:  

Mesh:

Year:  2014        PMID: 24515678     DOI: 10.1176/appi.neuropsych.12100240

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  17 in total

1.  Skin Conduction Levels Differentiate Frontotemporal Dementia From Alzheimer's Disease.

Authors:  Mario F Mendez; Sylvia S Fong; Mark M Ashla; Elvira E Jimenez; Andrew R Carr
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-04-06       Impact factor: 2.198

2.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

3.  Pathology of nNOS-Expressing GABAergic Neurons in Mouse Model of Alzheimer's Disease.

Authors:  Seungho Choi; Je-Seong Won; Steven L Carroll; Balasubramaniam Annamalai; Inderjit Singh; Avtar K Singh
Journal:  Neuroscience       Date:  2018-05-19       Impact factor: 3.590

4.  Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.

Authors:  Josephine Barnes; Jonathan W Bartlett; David A Wolk; Wiesje M van der Flier; Chris Frost
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Brain Mitochondrial Dysfunction: A Possible Mechanism Links Early Life Anxiety to Alzheimer's Disease in Later Life.

Authors:  Qixue Wang; Mengna Lu; Xinyu Zhu; Xinyi Gu; Ting Zhang; Chenyi Xia; Li Yang; Ying Xu; Mingmei Zhou
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

Review 6.  Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease.

Authors:  Kenneth M Heilman; Stephen E Nadeau
Journal:  Neurotherapeutics       Date:  2022-01-10       Impact factor: 6.088

7.  The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.

Authors:  Neus Falgàs; Isabel E Allen; Salvatore Spina; Harli Grant; Stefanie D Piña Escudero; Jennifer Merrilees; Rosalie Gearhart; Howard J Rosen; Joel H Kramer; William W Seeley; Thomas C Neylan; Bruce L Miller; Gil D Rabinovici; Lea T Grinberg; Christine M Walsh
Journal:  Eur J Neurol       Date:  2021-12-20       Impact factor: 6.288

Review 8.  Neurodegenerative disorders and gut-brain interactions.

Authors:  Alpana Singh; Ted M Dawson; Subhash Kulkarni
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

9.  Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Authors:  Melisa Gumus; Namita Multani; Michael L Mack; Maria Carmela Tartaglia
Journal:  Geroscience       Date:  2021-01-09       Impact factor: 7.581

Review 10.  Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline.

Authors:  Rossana Botto; Nicoletta Callai; Aurora Cermelli; Lorenzo Causarano; Innocenzo Rainero
Journal:  Neurol Sci       Date:  2022-04-23       Impact factor: 3.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.